A vitamin A byproduct could weaken the immune system's cancer-fighting ability, according to new Princeton University ...
Retinoic acid suppresses immune defenses against cancer, but a new drug KyA33 boosts vaccine success and slows tumor growth in animal models.
Unraveling the Subtypes and Functional Roles of Dendritic Cells in Cancer Immunity and Immunotherapy
Dendritic cells (DCs) are central players in cancer immunity, serving as the primary link between innate and adaptive immune responses. Their functional ...
A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...
Bria-IMT demonstrates a median overall survival of 15.6 months, surpassing historical data for heavily pretreated metastatic ...
Researchers sought to determine whether zanubrutinib combined with rituximab and lenalidomide would improve remission rates in older adults with newly diagnosed DLBCL.
Cancer cells have softer membranes than healthy cells. New nanoparticles exploit this physical difference to fuse selectively ...
Poolbeg Pharma plc - Peer-Reviewed POLB 001 LPS Challenge Trial Paper Published in Frontiers in Immunology 28 January 2026- Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage ...
Pancreatic cancer kills most patients within months of diagnosis, largely because symptoms don’t appear until the disease has already spread. Now, scientists at Tokyo University of Science have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results